About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Tennessee | 63 Studies

Clinical Trials Brain CancerTennessee

Brain Cancer Clinical Trials in Tennessee

Find 63 clinical trials for brain cancer near Tennessee. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 63 trials

TerminatedTP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade GliomaRATIONALE: The TP-38 toxin can locate tumor cells and kill them without harming normal cells. Giving TP-38 toxin directly into the tumor may kill more tumor cells.NCT00074334·Washington D.C., District of Columbia and 7 others TerminatedA Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent GliomaOncoGel™ is a new, experimental drug delivery system that allows the slow continuous release of paclitaxel (an approved intravenous anticancer drug), from a gel (ReGel™) over a…NCT00479765·Chicago, Illinois and 4 others RecruitingPilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical ProceduresThis pilot clinical study evaluates the safety and imaging performance of panitumumab-IRDye800 (pan800), a fluorescent, EGFR-targeted imaging agent - in patients undergoing…NCT07493447·Nashville, Tennessee

Brain Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

CompletedAdavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine GliomasThis phase I trial studies the side effects and the best dose of adavosertib when given together with local radiation therapy in treating children with newly diagnosed diffuse…NCT01922076·Birmingham, Alabama and 23 others

CompletedCilengitide in Treating Children With Refractory Primary Brain TumorsThis phase I trial is studying the side effects and best dose of cilengitide in treating children with recurrent, progressive, or refractory primary CNS tumors.NCT00063973·Memphis, Tennessee

CompletedDonepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain TumorsRATIONALE: Donepezil may help lessen confusion and fatigue and improve mood and quality of life in patients who have undergone radiation therapy for brain tumors.NCT00369785·Wichita, Kansas and 15 others

Active not recruitingPediatric Long-Term Follow-up and Rollover StudyA roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.NCT03975829·Phoenix, Arizona and 53 others

CompletedS0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or GliosarcomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00017147·Anchorage, Alaska and 162 others

CompletedDalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeRATIONALE: Dalteparin may stop the growth of cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth.NCT00028678·Tampa, Florida and 11 others

CompletedABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsThis phase I trial is studying the side effects and best dose of ABT-888 when given in combination with temozolomide in treating young patients with recurrent or refractory CNS…NCT00946335·Memphis, Tennessee

UnknownStudy of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerThe primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM for whom surgery is indicated.NCT00045968·Birmingham, Alabama and 85 others

CompletedTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsPhase I trial to study the safety of combining O6-benzylguanine with temozolomide in treating children who have recurrent or refractory brain tumors.NCT00052780·Memphis, Tennessee

WithdrawnStudy of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma MultiformeTransMID treatment or best standard of care for patients with advanced glioblastoma multiforme Glioblastoma multiforme (GBM) is a type of brain tumour.NCT00083447·La Jolla, California and 24 others

CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Chemotherapy uses different ways to stop tumor cells from dividing so they stop growing or die.NCT00002545·Birmingham, Alabama and 259 others

CompletedPhase I Study of APX005M in Pediatric Central Nervous System TumorsThis phase I trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor that is growing, spreading…NCT03389802·Los Angeles, California and 10 others

Completedp28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsThis phase I trial studies the side effects and best dose of azurin-derived cell-penetrating peptide p28 (p28) in treating patients with recurrent or progressive central nervous…NCT01975116·Los Angeles, California and 10 others

TerminatedRadiation Boost for Newly Diagnosed Glioblastoma MultiformeThe purpose of this study is to determine treatment related toxicity, tumor response, progression-free survival and quality of life of newly diagnosed Glioblastoma Multiforme…NCT00376103·Memphis, Tennessee

CompletedRadiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as tamoxifen may make the tumor cells more sensitive to radiation therapy.NCT00006388·Birmingham, Alabama and 256 others

Terminated3T MRI Biomarkers of Glioma Treatment ResponseThis pilot clinical trial studies advanced magnetic resonance imaging (MRI) techniques in measuring treatment response in patients with high-grade glioma.NCT01996527·Nashville, Tennessee

Page 1 of 4Next

Other Conditions in Tennessee

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia